382 related articles for article (PubMed ID: 24949448)
1. Immunomodulation of nanoparticles in nanomedicine applications.
Jiao Q; Li L; Mu Q; Zhang Q
Biomed Res Int; 2014; 2014():426028. PubMed ID: 24949448
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and immune-toxicological role of nanoparticles: Potential therapeutic applications.
Sau S; Dey A; Pal P; Das B; Maity KK; Dash SK; Tamili DK; Das B
Int Immunopharmacol; 2024 Jun; 135():112251. PubMed ID: 38781608
[TBL] [Abstract][Full Text] [Related]
3. Effects of engineered nanoparticles on the innate immune system.
Liu Y; Hardie J; Zhang X; Rotello VM
Semin Immunol; 2017 Dec; 34():25-32. PubMed ID: 28985993
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterials for direct and indirect immunomodulation: A review of applications.
Kubackova J; Zbytovska J; Holas O
Eur J Pharm Sci; 2020 Jan; 142():105139. PubMed ID: 31704342
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles and the immune system.
Zolnik BS; González-Fernández A; Sadrieh N; Dobrovolskaia MA
Endocrinology; 2010 Feb; 151(2):458-65. PubMed ID: 20016026
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility in regenerative nanomedicine.
Zor F; Selek FN; Orlando G; Williams DF
Nanomedicine (Lond); 2019 Oct; 14(20):2763-2775. PubMed ID: 31612774
[TBL] [Abstract][Full Text] [Related]
7. Poly(Glycerol)-Based Biomedical Nanodevices Constructed by Functional Programming on Inorganic Nanoparticles for Cancer Nanomedicine.
Komatsu N
Acc Chem Res; 2023 Jan; 56(2):106-116. PubMed ID: 36602954
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
9. Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.
Guo S; Xu C; Yin H; Hill J; Pi F; Guo P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1582. PubMed ID: 31456362
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxicity of Therapeutic Antibodies and Nanoparticles.
Özenver N; Efferth T
Crit Rev Immunol; 2020; 40(1):53-74. PubMed ID: 32421979
[TBL] [Abstract][Full Text] [Related]
11. Perspectives in immunopharmacology: the future of immunosuppression.
Boraschi D; Penton-Rol G
Immunol Lett; 2014 Oct; 161(2):211-5. PubMed ID: 24333342
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
13. Advances in studies of nanoparticle-biomembrane interactions.
He XC; Lin M; Li F; Sha BY; Xu F; Qu ZG; Wang L
Nanomedicine (Lond); 2015 Jan; 10(1):121-41. PubMed ID: 25597773
[TBL] [Abstract][Full Text] [Related]
14. The hurdles of nanotoxicity in transplant nanomedicine.
Nagy A; Robbins NL
Nanomedicine (Lond); 2019 Oct; 14(20):2749-2762. PubMed ID: 31642385
[TBL] [Abstract][Full Text] [Related]
15. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
Fasoli E
Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
[TBL] [Abstract][Full Text] [Related]
16. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
[TBL] [Abstract][Full Text] [Related]
17. Advances in Enantiomer-Dependent Nanotherapeutics.
Wang Y; Tay A
ACS Nano; 2023 Jun; 17(11):9850-9869. PubMed ID: 37267453
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
Shi J; Xiao Z; Kamaly N; Farokhzad OC
Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
[TBL] [Abstract][Full Text] [Related]
19. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
20. Progress in nano-drug delivery of artemisinin and its derivatives: towards to use in immunomodulatory approaches.
Charlie-Silva I; Fraceto LF; de Melo NFS
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S611-S620. PubMed ID: 30444132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
